Please Wait
Applying Filters...
menu
    • menu
    Seqens is an integrated global leader in pharmaceutical solutions & specialty ingredients, & custom-made solutions to our customers.

    Virtual Booth

    Contact Supplier

    Inke S.A: APIs manufacturing plant.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2025-04-21

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    With Fermion, start the journey of your innovative API.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2025-04-14

    Virtual Booth

    Contact Supplier

    Menu

    L-Ergothioneine

    ACTIVE PHARMA INGREDIENTS

    DIGITAL CONTENT

    PharmaCompass
    $ API Ref.Price (USD/KG) : 25,210Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Abinopharm congratulates EGT Synbio on FDA no objection letter
    Abinopharm congratulates EGT Synbio on FDA no objection letter

    24 Mar 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/03/24/3048269/0/en/Abinopharm-Inc-warmly-congratulates-partner-company-EGT-Synbio-on-receiving-no-objection-letter-from-the-FDA-for-their-GRAS-notification-of-Dr-Ergo-Ergothioneine.html

    GLOBENEWSWIRE
    24 Mar 2025
    Share Share
    The Rising Popularity of the 'Longevity Vitamin' - Ergothioneine
    The Rising Popularity of the 'Longevity Vitamin' - Ergothioneine

    30 Aug 2023

    // PRESS RELEASE

    https://www.bloomagebioactive.com/En/News/Info/13619

    PRESS RELEASE
    30 Aug 2023
    Share Share
    Exploring Together into Uncharted TerritoriesJourney Bloomage Biotech's in China
    Exploring Together into Uncharted TerritoriesJourney Bloomage Biotech's in China

    10 Aug 2023

    // PRESS RELEASE

    https://www.bloomagebioactive.com/En/News/Info/13539

    PRESS RELEASE
    10 Aug 2023
    Share Share